Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Treasury Shares (2019 - 2025)

OptimizeRx's Treasury Shares history spans 4 years, with the latest figure at $2000.0 for Q3 2025.

  • For Q3 2025, Treasury Shares changed 0.0% year-over-year to $2000.0; the TTM value through Sep 2025 reached $2000.0, changed 0.0%, while the annual FY2024 figure was $2000.0, 0.0% changed from the prior year.
  • Treasury Shares for Q3 2025 was $1.7 million at OptimizeRx, roughly flat from $1.7 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.7 million in Q1 2023 and bottomed at -$693246.0 in Q3 2022.
  • The 5-year median for Treasury Shares is $1.7 million (2023), against an average of $1.2 million.
  • The largest annual shift saw Treasury Shares skyrocketed 13292.31% in 2023 before it changed 0.0% in 2024.
  • A 4-year view of Treasury Shares shows it stood at $1214.0 in 2022, then skyrocketed by 64.74% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Treasury Shares are $2000.0 (Q3 2025), $2000.0 (Q2 2025), and $2000.0 (Q1 2025).